94 related articles for article (PubMed ID: 21824195)
21. Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice.
Lerche CM; Philipsen PA; Poulsen T; Wulf HC
Exp Dermatol; 2010 Nov; 19(11):973-9. PubMed ID: 20113348
[TBL] [Abstract][Full Text] [Related]
22. Assessment of atrophogenicity of popularly prescribed topical corticosteroids.
Dykes PJ; Marks R; Blakemore CB
Br J Clin Pract; 1978 Dec; 32(12):345-8. PubMed ID: 737113
[No Abstract] [Full Text] [Related]
23. Prospects for future topical glucocorticoid development.
Brattsand R; Särnstrand B
Acta Derm Venereol Suppl (Stockh); 1989; 151():37-46; discussion 47-52. PubMed ID: 2624065
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid action on skin collagen: overview on clinical significance and consequences.
Nuutinen P; Autio P; Hurskainen T; Oikarinen A
J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):361-2. PubMed ID: 11730056
[No Abstract] [Full Text] [Related]
25. Side effects of potent topical corticosteroids.
Jackson R
Can Med Assoc J; 1978 Jan; 118(2):173-4. PubMed ID: 93507
[No Abstract] [Full Text] [Related]
26. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
27. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
Lavker RM; Kaidbey K; Leyden JJ
J Am Acad Dermatol; 1992 Apr; 26(4):535-44. PubMed ID: 1597538
[TBL] [Abstract][Full Text] [Related]
28. Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy.
Lesovaya E; Agarwal S; Readhead B; Vinokour E; Baida G; Bhalla P; Kirsanov K; Yakubovskaya M; Platanias LC; Dudley JT; Budunova I
J Invest Dermatol; 2018 Sep; 138(9):1935-1944. PubMed ID: 29596905
[TBL] [Abstract][Full Text] [Related]
29. [Reducing the dosage by new technology].
Steinhorst M
Hautarzt; 2001 Jan; 52(1):p following 90 (91). PubMed ID: 11220248
[No Abstract] [Full Text] [Related]
30. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
31. Skin and subcutanous fat atrophy after corticosteroid injection for medial epicondylitis.
Beyzadeoglu T; Bekler H; Gokce A
Orthopedics; 2011 Aug; 34(8):570. PubMed ID: 21800809
[No Abstract] [Full Text] [Related]
32. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for using superpotent topical steroids.
Prawer SE; Katz HI
Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
[TBL] [Abstract][Full Text] [Related]
34. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
35. Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
[TBL] [Abstract][Full Text] [Related]
36. Mineralocorticoid receptor blockade improves glucocorticoid-induced skin atrophy but partially ameliorates anti-inflammatory actions in an irritative model in human skin explants.
Boix J; Nguyen VT; Farman N; Aractingi S; Pérez P
Exp Dermatol; 2018 Feb; 27(2):185-187. PubMed ID: 29178328
[TBL] [Abstract][Full Text] [Related]
37. [A study of changes in the ratio of collagen types in skin after long-term treatment with topical glucocorticoids].
Kuo KW; Sheu HM; Yu HS; Shen TC; Chang CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 May; 6(5):224-30. PubMed ID: 2362301
[TBL] [Abstract][Full Text] [Related]
38. Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound.
Korting HC
Curr Probl Dermatol; 1993; 21():114-21. PubMed ID: 8299364
[No Abstract] [Full Text] [Related]
39. Local atrophy of the cheek skin and hirsutism in a 3-year-old child following corticosteroids treatment.
Pietrzak A; Chodorowska G; Borowiec M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):227-30. PubMed ID: 15314990
[TBL] [Abstract][Full Text] [Related]
40. [Practical aspects of local steroid treatment].
Gehring W; Gloor M
Ther Umsch; 1989 Feb; 46(2):94-7. PubMed ID: 2522687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
